ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine
August 12, 2021AzurRx BioPharma has expanded the ongoing Phase II RESERVOIR clinical trial of FW-1022 for the treatment of Covid-19-related gastrointestinal (GI) infections in Ukraine. -
AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares
July 28, 2021AzurRx BioPharma, Inc. announced today the closing of its previously announced underwritten public offering of 10,454,546 shares of common stock of the Company.
Pharma Sources Insight January 2025
